RNA editing and short variant of serotonin 2C receptor mRNA in neuronally differentiated NG108-15 cells

Journal of Pharmacological Sciences

Volumn 96, Issue 2, 2004, Pages 164-169

  Tohda, Michihisa ^a   Sukma, Monrudee ^a   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Deaminase; Neuronal differentiation; RNA editing; Serotonin; Short variant

Indexed keywords

ADENOSINE DEAMINASE; CYTOSINE DEAMINASE; MESSENGER RNA; RNA; RNA DIRECTED DNA POLYMERASE; SEROTONIN 2C RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION; RNA EDITING; SEQUENCE ANALYSIS;

EID: 7944221575     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0040227     Document Type: Article

References (19)

1. Julius D, MacDermott AB, Axel R, Jessell TM. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science. 1988;241:558-564.
2. Molineaux SM, Jessell TM, Axel R, Julius D. 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA. 1989;86:6793-6797.
3. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 1997;387: 303-308.
4. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem. 1999;274:9472-9478.
5. Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, et al. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol. 1996;50:799-807.
6. Tohda M, Sukma M, Nomura Y, Watanabe H. The mRNA expression of serotonin 2C subtype receptors uncoupled with inositol hydrolysis in NG108-15 Cells. Jpn J Pharmacol. 2002;90:138-144.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
8. Tohda M, Kumagai C, Nomura Y. Effects of the simultaneous application of dibutyryl cAMP and phorbol ester on morphological differentiation in NG108-15 cells. Neurochem Int. 1991;19:255-260.
9. Kumagai C, Tohda M, Isobe M, Nomura Y. Involvement of growth-associated protein-43 with irreversible neurite outgrowth by dibutyryl cyclic AMP and phorbol ester in NG108-15 cells. J Neurochem. 1992;59:41-47.
10. Tohda C, Nagai S, Tohda M, Nomura Y. A novel factor, TA20, involved in neuronal differentiation: cDNA cloning and expression. Neurosci Res. 1995;23:21-27.
11. Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem. 2000; 74:1290-1300.
12. Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature. 1999;399:75-80.
13. Price RD, Sanders-Bush E. RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Mol Pharmacol. 2000;58:859-862.
14. Herrick-Davis K, Grinde E, Niswender CM. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem. 1999;73: 1711-1717.
15. Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci. 2002; 22:10529-10532.
16. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron. 2002; 34:349-356.
17. Julius D, Livelli TJ, Jessell TM, Axel R. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science. 1989;244:1057-1062.
18. Miyagi T, Koshida K, Hori O, Konaka H, Katoh H, Kitagawa Y, et al. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. J Gene Med. 2003;5:30-37.
19. Liu J, Zou WG, Lang MF, Luo J, Sun LY, Wang XN, et al. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter. Int J Oncol. 2002;21:661-666.